Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy

References

• Löscher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72(3):606–638. doi:10.1124/pr.120.019539
   PubMed Web of Science ®Google Scholar
• Fine A, Wirrell EC. Seizures in children. Ped Rev. 2020;41(7):321–347. doi:10.1542/pir.2019-0134
   PubMed Web of Science ®Google Scholar
• Tan NN, Tang HL, Lin GW, et al. Epigenetic downregulation of Scn3a expression by valproate: a possible role in its anticonvulsant activity. Mol Neurobiol. 2017;54(4):2831–2842. doi:10.1007/s12035-016-9871-9
   Web of Science ®Google Scholar
• Shinnar S, O’Dell C, Berg AT. Mortality following a first unprovoked seizure in children: a prospective study. Neurology. 2005;64(5):880–882. doi:10.1212/01.wnl.0000152893.72146.92
   Web of Science ®Google Scholar
• Garcia Pierce J, Aronoff S, Del Vecchio M. Systematic review and meta-analysis of seizure recurrence after a first unprovoked seizure in 815 neurologically and developmentally normal children. J Child Neurol. 2017;32(13):1035–1039. doi:10.1177/0883073817726461
   Web of Science ®Google Scholar
• Sartori S, Nosadini M, Tessarin G, et al. First-ever convulsive seizures in children presenting to the emergency department: risk factors for seizure recurrence and diagnosis of epilepsy. Dev Med Child Neurol. 2019;61(1):82–90. doi:10.1111/dmcn.14015
   Web of Science ®Google Scholar
• Jahromi SR, Togha M, Fesharaki SH, et al. Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. Seizure. 2011;20(4):343–346. doi:10.1016/j.seizure.2010.12.011
   Web of Science ®Google Scholar
• Belcastro V, D’Egidio C, Striano P, Verrotti A. Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res. 2013;107(1–2):1–8. doi:10.1016/j.eplepsyres.2013.08.016
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu P, Tang HL, et al. Valproate-induced epigenetic upregulation of hypothalamic Fto expression potentially linked with weight gain. Cell Mol Neurobiol. 2020. doi:10.1007/s10571-020-00895-2
   Web of Science ®Google Scholar
• Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. The pharmacogenomics of valproic acid. J Hum Genet. 2017;62(12):1009–1014. doi:10.1038/jhg.2017.91
   PubMed Web of Science ®Google Scholar
• Berg AT, Langfitt JT, Testa FM, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia. 2008;49(4):608–614. doi:10.1111/j.1528-1167.2007.01461.x
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5(7):553–564. doi:10.1038/nrn1430
   PubMed Web of Science ®Google Scholar
• Cunningham MO, Woodhall GL, Jones RS. Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology. 2003;45(7):907–917. doi:10.1016/s0028-3908(03)00270-3
   Web of Science ®Google Scholar
• Löscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol. 1999;58(1):31–59. doi:10.1016/s0301-0082(98)00075-6
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Kang JQ. Molecular pathology of genetic epilepsies associated with GABAA receptor subunit mutations. Epilepsy Curr. 2009;9(1):18–23. doi:10.1111/j.1535-7511.2008.01278.x
   Web of Science ®Google Scholar
• Bhat MA, Guru SA, Mir R, et al. Association of GABAA receptor gene with epilepsy syndromes. J Mol Neurosci. 2018;65(2):141–153. doi:10.1007/s12031-018-1081-7
   Web of Science ®Google Scholar
• Haerian BS, Baum L, Kwan P, et al. Contribution of GABRG2 polymorphisms to risk of epilepsy and febrile seizure: a multicenter cohort study and meta-analysis. Mol Neurobiol. 2016;53(8):5457–5467. doi:10.1007/s12035-015-9457-y
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang X, Zhou L, Wu Q, Han Y. Analysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatment. Clin Transl Sci. 2021. doi:10.1111/cts.12997
   Web of Science ®Google Scholar
• Milanovska M, Cvetkovska E, Panov S. Association of rs211037 GABRG2 gene polymorphism with susceptibility to idiopathic generalized epilepsy. Medicinski Glasnik. 2021;18(2). doi:10.17392/1367-21
   Google Scholar
• Abou El Ella SS, Tawfik MA, Abo El Fotoh WMM, Soliman OAM. The genetic variant “C588T” of GABARG2 is linked to childhood idiopathic generalized epilepsy and resistance to antiepileptic drugs. Seizure. 2018;60:39–43. doi:10.1016/j.seizure.2018.06.004
   PubMed Web of Science ®Google Scholar
• Gitaí LL, de Almeida DH, Born JP, et al. Lack of association between rs211037 of the GABRG2 gene and juvenile myoclonic epilepsy in Brazilian population. Neurol India. 2012;60(6):585–588. doi:10.4103/0028-3886.105191
   Web of Science ®Google Scholar
• Balan S, Sathyan S, Radha SK, Joseph V, Radhakrishnan K, Banerjee M. GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures. Pharmacogenet Genomics. 2013;23(11):605–610. doi:10.1097/fpc.0000000000000000
   Web of Science ®Google Scholar
• Butilă AT, Zazgyva A, Sin AI, Szabo ER, Tilinca MC. GABRG2 C588T gene polymorphisms might be a predictive genetic marker of febrile seizures and generalized recurrent seizures: a case-control study in a Romanian pediatric population. Arch Med Sci. 2018;14(1):157–166. doi:10.5114/aoms.2016.63739
   PubMed Web of Science ®Google Scholar
• Ponnala S, Chaudhari JR, Jaleel MA, et al. Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption. Genet Test Mol Biomarkers. 2012;16(6):550–557. doi:10.1089/gtmb.2011.0225
   Web of Science ®Google Scholar
• Kumari R, Lakhan R, Kalita J, Misra UK, Mittal B. Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population. Seizure. 2010;19(4):237–241. doi:10.1016/j.seizure.2010.02.009
   Web of Science ®Google Scholar
• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521. doi:10.1111/epi.13709
   PubMed Web of Science ®Google Scholar
• Wolking S, Moreau C, Nies AT, et al. Testing association of rare genetic variants with resistance to three common antiseizure medications. Epilepsia. 2020;61(4):657–666. doi:10.1111/epi.16467
   Web of Science ®Google Scholar
• Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 2016;15(2):210–218. doi:10.1016/s1474-4422(15)00314-2
   PubMed Web of Science ®Google Scholar
• Fan X, Chen Y, Li W, et al. Genetic polymorphism of ADORA2A is associated with the risk of epilepsy and predisposition to neurologic comorbidity in Chinese Southern Children. Front Neurosci. 2020;14:590605. doi:10.3389/fnins.2020.590605
   Web of Science ®Google Scholar
• Bai X, Xu C, Wen D, et al. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients. Psychopharmacol. 2018;235(9):2665–2673. doi:10.1007/s00213-018-4960-2
   Web of Science ®Google Scholar
• Kaushik S, Chopra D, Sharma S, Aneja S. Adverse drug reactions of anti-epileptic drugs in children with epilepsy: a cross-sectional study. Curr Drug Saf. 2019;14(3):217–224. doi:10.2174/1574886314666190311112710
   Web of Science ®Google Scholar
• Lauschke VM, Ingelman-Sundberg M. Prediction of drug response and adverse drug reactions: from twin studies to next generation sequencing. Eur J Pharm Sci. 2019;130:65–77. doi:10.1016/j.ejps.2019.01.024
   PubMed Web of Science ®Google Scholar
• Xu S, Chen Y, Zhao M, Guo Y, Wang Z, Zhao L. Population pharmacokinetics of valproic acid in epileptic children: effects of clinical and genetic factors. Eur J Pharm Sci. 2018;122:170–178. doi:10.1016/j.ejps.2018.06.033
   PubMed Web of Science ®Google Scholar
• Olsen RW. GABA(A) receptor: positive and negative allosteric modulators. Neuropharmacology. 2018;136(Pt A):10–22. doi:10.1016/j.neuropharm.2018.01.036
   PubMed Web of Science ®Google Scholar
• Salam SM, Rahman HM, Karam RA. GABRG2 gene polymorphisms in Egyptian children with simple febrile seizures. Indian J Pediatr. 2012;79(11):1514–1516. doi:10.1007/s12098-011-0564-0
   Web of Science ®Google Scholar
• Krampfl K, Maljevic S, Cossette P, et al. Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy. Eur J Neurosci. 2005;22(1):10–20. doi:10.1111/j.1460-9568.2005.04168.x
   Web of Science ®Google Scholar
• Fan H, Wu Y, Zhou X, et al. Pathway-based genome-wide association studies for two meat production traits in Simmental cattle. Sci Rep. 2015;5:18389. doi:10.1038/srep18389
   Web of Science ®Google Scholar
• Zhang X, van den Pol AN. Rapid binge-like eating and body weight gain driven by zona incerta GABA neuron activation. Science. 2017;356(6340):853–859. doi:10.1126/science.aam7100
   PubMed Web of Science ®Google Scholar
• Zhu C, Jiang Z, Xu Y, et al. Profound and redundant functions of arcuate neurons in obesity development. Nat Metabol. 2020;2(8):763–774. doi:10.1038/s42255-020-0229-2
   Google Scholar
• Sandoval-Salazar C, Ramírez-Emiliano J, Trejo-Bahena A, Oviedo-Solís CI, Solís-Ortiz MS. A high-fat diet decreases GABA concentration in the frontal cortex and hippocampus of rats. Biol Res. 2016;49:15. doi:10.1186/s40659-016-0075-6
   PubMed Web of Science ®Google Scholar
• Choo E, Wong L, Chau P, Bushnell J, Dando R. Offspring of obese mice display enhanced intake and sensitivity for palatable stimuli, with altered expression of taste signaling elements. Sci Rep. 2020;10(1):12776. doi:10.1038/s41598-020-68216-7
   Web of Science ®Google Scholar
• Avau B, Bauters D, Steensels S, et al. The gustatory signaling pathway and bitter taste receptors affect the development of obesity and adipocyte metabolism in mice. PLoS One. 2015;10(12):e0145538. doi:10.1371/journal.pone.0145538
   Web of Science ®Google Scholar
• Hwang I, Jo K, Shin KC, et al. GABA-stimulated adipose-derived stem cells suppress subcutaneous adipose inflammation in obesity. Proc Natl Acad Sci U S A. 2019;116(24):11936–11945. doi:10.1073/pnas.1822067116
   PubMed Web of Science ®Google Scholar
• Covelo IR, Patel ZI, Luviano JA, Stratford TR, Wirtshafter D. Manipulation of GABA in the ventral pallidum, but not the nucleus accumbens, induces intense, preferential, fat consumption in rats. Behav Brain Res. 2014;270:316–325. doi:10.1016/j.bbr.2014.05.032
   Web of Science ®Google Scholar